We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Kromek Group Plc | LSE:KMK | London | Ordinary Share | GB00BD7V5D43 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.40 | 5.84% | 7.25 | 7.00 | 7.50 | 7.25 | 6.85 | 6.85 | 1,554,889 | 16:18:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Miscellaneous Metal Ores,nec | 17.31M | -6.1M | -0.0102 | -7.11 | 43.52M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/7/2018 08:04 | announces 2 contracts today with US Government re Defence, worth up to $3.3m. Encouraging news, that de-risks our FY revenue targets. Updated note and analysis freely available here: | edmonda | |
23/7/2018 07:31 | Excellent stuff ! ....always know it's really good news when I open the thread to see multiple "Chimers" posts | onedayrodders | |
23/7/2018 07:28 | I smell a PLACING. | chimers | |
23/7/2018 07:21 | Excellent contracts, just need some patience here, obviously there are a few that have none or probably just attention seeking without actually invested here lol Happy with this morning’s news. Chart recovery off the early double bottom bodes well. GLA | ny boy | |
23/7/2018 07:17 | RNSKromek secures two contracts worth up to $3.3 million from US governmentNew contracts to develop next generation radiation detection solutions for national defence and security Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security and nuclear markets, is pleased to announce that it has been awarded two new contracts from the US Department of Homeland Security ("DHS") and the Defense Threat Reduction Agency ("DTRA"), an agency of the US Department of Defense, to develop next generation radiation detection solutions for the purposes of national defence and security. The two contracts are worth a minimum of $2.6 million to be delivered over the next three years, with a potential two-year extension to $3.3 million, with revenue generation commencing under both contracts in the current financial year. | susiebe | |
23/7/2018 07:16 | Do we have Computed Tomography in our security division? | josephrobert | |
03/7/2018 12:52 | Don't forget copyright rules..some on ADVFN are particularly sensitive about such things | mirabeau | |
03/7/2018 12:38 | Dr Arnab Basu, chief executive of Sedgefield-based | susiebe | |
03/7/2018 12:36 | Superficially reasonable results, but the underlying position seems very weak. Receivables at £11.3m are almost equal to the annual revenue of £11.8m, suggestive of aggressive revenue recognition. Amazingly, £10.8m of cash has been burnt. At this rate the company will run out of money soon. These financial metrics are unusual and very weak. Avoid/sell. | wiltshire sage | |
03/7/2018 12:32 | That's Simon Thompson having an effect on the share price. ST clearly holds more weight than that numpty! | pastybap | |
03/7/2018 12:16 | Keep going Chimers, having a great effect on share price | pistonbroke1 | |
03/7/2018 11:13 | Chimers, stop sitting on the fence and tell us what you really think. ;-) | owenski | |
03/7/2018 10:20 | Walbrock’s opinions on Kromek Kromek business is growing and will likely break even on EBITDA, but on EBIT you will have to wait beyond 2020. Meanwhile, development costs (capitalized expenses) have risen to £11.6m in 2017 and will rise further. The question investor should ask: “Will the company’s valuation and share price survive when cash balance starts to fall?” On that basis, I’m leaning towards that the share price will remain under pressure because of the amount of time it will make a profit. | chimers | |
03/7/2018 10:18 | · Loss before tax for the year was £2.5m (2016/17: £3.8m loss) · Cash and cash equivalents at 30 April 2018 were £9.5m (31 October 2017: £15m) | chimers | |
03/7/2018 10:15 | FY19 set to be another ‘break-through FY18 was pivotal for Kromek in many ways. Not least, because it was the first time ever EBITDA turned positive (£482k vs -£1,462k) - reflecting record turnover of £11,845k, up 32.1% LFL (LY £8,968k; +37% constant currency) and favourable operational gearing (gross margin 56.4% vs 57.1%). However this is just the start. In our view, strong double digit growth should continue for the foreseeable future, with FY19 setting up to be another landmark year. This time achieving cashflow neutrality, together with winning a number of new orders with blue chip OEMs and governments across the globe. The greatest demand expected to come from SPECT (single photon emission computed tomography), a $100m addressable market, and nuclear detection (worth >$1bn) on the back of KMK’s best-in-class ‘dirty bomb’ detector, the D3S. .... | cottoner | |
03/7/2018 10:09 | · Loss before tax for the year was £2.5m (2016/17: £3.8m loss) · Cash and cash equivalents at 30 April 2018 were £9.5m (31 October 2017: £15m) | chimers | |
03/7/2018 10:02 | Huge growth and job creation predicted at pioneering NETPark tech firm Kromek 'Dr Basu said the business has the potential to treble, potentially quadruple over the next five to 10 years, as commercialisation is ramped up even further in its two biggest markets.' | cottoner | |
03/7/2018 09:18 | STOCKPEDIA SAY .................AVO | chimers | |
03/7/2018 09:18 | · Loss before tax for the year was £2.5m (2016/17: £3.8m loss) · Cash and cash equivalents at 30 April 2018 were £9.5m (31 October 2017: £15m) | chimers |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions